News Digest 25.03.2024 — 27.03.2024
Regulators
Hospitals were allowed to buy equipment worth up to 400 thousand rubles at the expense of compulsory medical insurance funds
The government has made changes to the Program of State Guarantees for the provision of free medical care to citizens for 2024 and for the planning period of 2025 and 2026. Resolution No. 371 of March 23, 2024 is available on MV. Previously, this measure was initiated by the Ministry of Health, MV reported.
Now medical organizations will be able to purchase equipment, production and household supplies in the amount of up to 400 thousand rubles. per unit at the expense of compulsory medical insurance funds. Previously, this limit did not exceed 100 thousand rubles. In addition, the tariff structure includes the costs of medical organizations for maintenance and repair of such equipment and inventory.
Also, due to the fact that part of the volume of high-tech medical care (HTMC) from 2024 is provided within the framework of the basic compulsory medical insurance program, the decree added increasing coefficients to the salaries of health workers providing such medical care. We are talking about 23 methods of VMP in six profiles: obstetrics and gynecology, ophthalmology, pediatrics, cardiovascular surgery, traumatology and orthopedics, urology.
Manufacturers saw risks in the bill introducing uniform public procurement rules
It is necessary to provide for the possibility of simultaneous application of the “second odd one out” rule, as well as the “conditional reduction” mechanism of 15% in public procurement. This will give a greater advantage to domestic full-cycle drugs. This proposal was voiced by the Chairman of the Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, Alexey Kedrin, at a conference of the Kommersant newspaper, reports the FV correspondent.
We are talking about a bill that should unify incentive and restrictive mechanisms for government procurement of domestic products. The State Duma approved the document, which amends the Law on Public Procurement for State and Municipal Needs (FZ-44 of 04/05/2013) and the Law on Procurement by State-Owned Enterprises (FZ-223 of 07/18/2011), in the first reading on March 20.
It involves the introduction of the “second odd one out” rule, according to which applications offering foreign drugs will be rejected if at least one application with a Russian product is submitted to participate in the procurement. Replacing Russian goods with foreign ones if restrictions are established is also not allowed.
It is planned to include in both laws the existing “conditional reduction” mechanism, which provides for a reduction (or increase) by 15% in the price offers of procurement participants offering Russian products. The mechanism allows you to improve the position of such a procurement participant and increase the likelihood of his victory. If successful, the contract will be concluded at the price offered by such bidder without taking into account such reduction or increase.
At the same time, as Kedrin noted, the bill does not provide for the possibility of using these two mechanisms simultaneously in order to give greater advantages to a drug produced precisely through the full cycle in Russia.
According to the association, it is necessary to make changes to the bill that will allow the use of the “second wheel” and additionally provide a preference of 15% for goods of Russian origin with a higher technological level of localization of production over goods of Russian origin with a lower technological level of localization of production.
At the same time, such an advantage should be provided both after applying the “second odd one out” rule and excluding an application with an offer to supply goods of foreign origin, and regardless of the rule, when applications with an offer to supply goods of Russian origin with different levels of localization initially participate in the auction.
Market news
In the Primorsky Territory, production of plastic products for medicine will be organized for 250 million rubles
A new resident of the priority development territory (ASEZ) "Primorye" - LLC "Primorsky Molded Plastics Plant" - plans this year to open the production of plastic products and polymer packaging for use in the fields of medicine, pharmaceuticals, food production, fish processing, cosmetics and household chemicals. 250 million rubles will be invested in the project, 60 jobs will be created there.
Most of the investments will be spent on the purchase of lathes and milling machines for the workshop, as well as packaging robots, molds, ventilation, auxiliary and other equipment. The supplier of polymer raw materials will be the petrochemical company Sibur Holding.
According to the general director of the Primorsky injection molding plastics plant, Vladislav Pomerantsev, an advanced approach will be applied to production, which will be expressed in the use of automated quality control systems and “smart” technologies to increase efficiency. There will also be an emphasis on ensuring that all products meet environmental standards.
The enterprise will be located in Industrial Park Primorye LLC (resident of the Primorye ASEZ) - the first private industrial park in the Primorsky Territory. The total volume of investments from 117 residents of the ASEZ to date has amounted to 129 billion rubles, of which 24 billion rubles have gone into the regional economy.
According to SPARK, Primorsky Molded Plastics Plant LLC was registered at the end of February 2024, its activities include the production of technical and industrial textile products, paper products for household and sanitary purposes, plastic products for packaging goods, and more. The director and sole owner of the company is Vladislav Pomerantsev, who also owns two more enterprises: Volginsky Molded Plastics Plant LLC and Omsk Molded Plastics Plant LLC.
In August 2023, the Inpline company, specializing in the production of plastic containers, decided to begin production of vacuum tubes for blood collection in the Perm region. 112 million rubles were invested in the project, most of which was received in the form of a preferential loan from the Federal Investment Fund.
Transformation of the domestic manufacturer will support Russian medicine
From April 2024, SIBUR, Russia’s largest producer of polymers, one of the main components in medical equipment and consumables, is moving to an industry-based business management model. To replace the previously existing directorates, the holding will create industry divisions, one of which will serve the needs of domestic medicine.
The goal of the changes at SIBUR is to support industries that are strategically important for the country. The Medicine division created within the holding structure is designed to expand the capabilities of Russian manufacturers in the field of medicine, hygiene and medical pharmaceutical products by stimulating the production and consumption of domestic solutions, searching for new niches for their use and, as a result, reducing imports of finished products and their components.
Critical dependence on imported materials has been an obstacle to the development of the Russian medical industry for many years. Disposable syringes and gloves, medical clothing, laboratory products, systems for infusion and transfusion therapy are among the most widespread (80% of the total market share of medical products) and popular categories of medical products that use polymer materials. The potential for import substitution of polymers in the listed five categories alone is about 100 thousand tons per year.
As part of the industry transformation, SIBUR is focusing on the development of branded solutions for import substitution of finished products in hygiene, medical devices and pharmaceuticals. The company has already developed special medical grades of polypropylene and polyethylene for packaging infusion medical solutions and is developing grades of polymers that are stable to radiation sterilization, grades of polypropylene for the production of soft nonwoven materials used in hygiene products.
Active work is being carried out jointly with the pharmaceutical production market. SIBUR is developing components that are close to the brands produced by the company. Work is carried out along the entire chain: from chemists who work on the quality of raw materials, with the participation of manufacturers of the active pharmaceutical substance, and ending with the manufacturers of the pharmaceutical product. The result of this work will be the creation of new Russian drugs from high-quality domestic raw materials. This fully corresponds to the state goals of ensuring independence from imports and the objectives of localizing pharmaceutical production.
In addition to having a set of medically relevant brands in its portfolio, SIBUR will continue to provide marketing, R&D, technical and raw material support to initiatives for creating new production facilities for medical devices in the Russian Federation and to study the prospects for replacing traditional materials with modern polymer solutions.
SIBUR notes that they feel the need of Russian manufacturers of medical equipment and products for modern and high-quality raw materials. The industry approach will allow us, together with market participants, to develop comprehensive solutions for the development of medical technologies in Russia.
Roszdravnadzor institutions will be able to receive subsidies to support the implementation of medical devices with AI
Roszdravnadzor has made changes to the Procedure for distributing subsidies to departments subordinate to the service, expanding the list of purposes for which subsidies can be spent. New tasks include classification of medical products, analysis and collection of statistics on the circulation of medical products, as well as methodological assistance with the introduction of medical products based on artificial intelligence (AI) technologies in the regions.
Amendments were made to Order No. 4027 dated May 11, 2021. The list of purposes for which a subsidy can be directed has been supplemented with four items. Among them are the formation and maintenance of a nomenclature classification of medical devices, analysis, monitoring, information and analytical support and data processing in the field of circulation of medical devices and other segments for which the department is responsible.
Two more areas for receiving subsidies are providing methodological support and coordination of the implementation of medical products based on artificial intelligence technologies in the regions and reports on their implementation, as well as the formation of a system of measures for the implementation of specialized medical devices during the “Healthcare” national project.
In February 2024, the Ministry of Health compiled recommendations for regions on the procurement of medical products with AI. The Regulations include recommendations for the acquisition and implementation of software with artificial intelligence technology related to medical devices that have passed state registration in the manner established by the Government of the Russian Federation, or have been registered in accordance with the laws of the EAEU.
With the support of the Russian Ministry of Health, in 2023, 106 medical products with artificial intelligence were introduced in 85 constituent entities of the Russian Federation. 368.8 million rubles from the federal budget and 79.5 million rubles from the regional budget were allocated for the purchase of such solutions. With the help of AI, 22 million records were analyzed, in six regions, voice-filling services for documents are used, and in 29, virtual assistants with AI are used to make appointments with a doctor. In 2024, three solutions based on artificial intelligence should work in practical healthcare in each region.
MISIS has improved the method of producing alloys for joint prosthetics
Specialists from MISIS University have proposed a more effective technology for producing a new generation titanium alloy for joint replacement. As reported in the press service of NUST MISIS, the innovation will help create more durable hip joint endoprostheses using 3D printing in the future and avoid repeated operations for many patients.
Previously, an international team of scientists from NUST MISIS with colleagues from universities in Austria and Japan developed a biomedical alpha-beta titanium alloy of titanium, iron, copper and tin, which has high mechanical properties and does not contain components that cause negative immune reactions in the body.
“In a new work, MISIS University researchers studied the effect of selective laser melting on it. This is a process of selective melting of layers of metal powder using a laser beam, which allows precise control of the microstructure and properties of manufactured elements,” the press service said.
Scientists have identified the optimal manufacturing process, which produces samples with the most suitable mechanical characteristics, without cracks, and with high resistance to corrosion in a biological environment. The mode may be useful in the development of new biomedical alloys, which will become the basis for personalized endoprostheses created using additive technologies.
Source: https://nauka.tass.ru/nauka/20362587
Other
Sechenov University has developed a glove to restore motor skills after a stroke
A prototype of a glove for restoring hand motor skills after stroke and injury was created by specialists from the Sechenov University of the Russian Ministry of Health. The device allows you to automatically bend the patient's fingers to restore their mobility. The work was carried out within the framework of the Priority 2030 strategic academic leadership program.
Stroke and other neurological diseases, as well as injuries, can lead to weakening and impaired mobility of the fingers and hands. It is possible to restore motor skills with the help of physical therapy, but the patient does not always have the opportunity to work with a specialist. Independent exercises may be impossible with severe lesions, and sometimes patients neglect exercise. You can increase your chances of recovery by automating the process using special devices.
Developed by specialists from the laboratory of controlled bionic systems, the device is a glove with five silicone actuators, which are located on top of the patient’s fingers and, under the influence of compressed air, change shape, helping to bend the fingers. Scientists began creating the glove with mathematical modeling of actuators. The researchers were able to find a way to mold silicone “fingers” entirely to avoid the need to glue the elements together: the seams could eventually begin to leak air, which would make the device unusable.
In Moscow, the list of diseases for analysis by “computer vision” will be expanded to 54
The list of diseases for which decisions will be made based on “computer vision” will be expanded to 54 in Moscow. The mayor of the capital, Sergei Sobyanin, announced this on his Telegram channel.
“Moscow radiologists are ready to test and implement new artificial intelligence services for radiology studies. This year, the list of diseases for which we make decisions based on computer vision technologies will be expanded to 54,” Sobyanin wrote.
According to him, among them are destruction of the lung, changes in the soft tissues of the chest and blood vessels of the brain. The list of AI programs for diagnosing childhood pathologies, including dysplastic changes in the hip joint, is also expanding.
“Since February, we have opened access to the platform with services for all medical organizations in Russia. It operates on the basis of the Center for Diagnostics and Telemedicine of the Moscow Department of Health,” the mayor recalled
Source: https://tass.ru/obschestvo/20241051
The expert stated that there is no shortage of test strips for glucometers in Russia
There is no shortage of test strips for glucometers in Russia, Natalya Mokrysheva, director of the National Medical Research Center for Endocrinology of the Russian Ministry of Health, corresponding member of the Russian Academy of Sciences, told TASS.
Earlier, the Izvestia newspaper reported a drop in sales of test strips in Russian pharmacies. Experts interviewed by the publication suggested that this indicates that foreign manufacturers have reduced supplies, while Russian ones have not yet had time to increase production and fill the vacant niche.
“There is no shortage of test strips in the Russian Federation,” Mokrysheva said.
She added that more than 10 manufacturers of glucometers and test strips for them are represented in Russia, among them with production completely localized in the Russian Federation: Satellite, Diakont, Glucocard.
Source: https://tass.ru/obschestvo/20239615
Rostec launched a system for remote monitoring of the condition of pregnant women
The Rostec digital platform “Personal Medical Assistants” has added the ability to track the condition of a pregnant woman, the press service of the state corporation reported on March 18. New medical products – fetal monitors for monitoring the fetal heartbeat – will be connected to the system, which allows for remote monitoring of health indicators. In addition, pregnant women participating in the project will be given tonometers and glucometers.
The results of measurements of glucose levels in capillary blood, systolic and diastolic pressure, heart rate of the mother and child, as prescribed by the doctor, will be sent to the Personal Medical Assistants platform, from where they will be transferred to medical information systems for the doctor to monitor the condition of the woman and her unborn child at different stages pregnancy.
The project starts in March at the Mother and Child hospital in Moscow and medical network clinics in Yaroslavl, the Astrakhan and Vladimir regions, the Altai, Bashkortostan and Sakha (Yakutia) republics. Methodological management of the project will be carried out by the National Medical Research Center of Obstetrics, Gynecology and Perinatology named after. acad. IN AND. Kulakov together with Russian National Research Medical University named after. N.I. Pirogov.
The information system “Personal Medical Assistants” was launched at the beginning of 2023 for remote monitoring of the health status of people with chronic diseases. More than 37 thousand medical devices are already registered in it. The system operator is Ruselectronics.
SSMU scientists have developed a method for identifying skin tumors using artificial intelligence
A method for identifying skin tumors based on non-invasive studies followed by mathematical analysis using artificial intelligence was developed by scientists from SSMU. According to them, the method allows you to accurately determine the stage of tumor development and choose the right treatment tactics. The results were published in the journal Diagnostics.
Sechenov University will create a silent and compact mattress for bedridden patients
A prototype of a thin and silent anti-decubitus mattress is being developed by specialists from the laboratory of controlled bionic systems at Sechenov University of the Russian Ministry of Health. The device makes it possible to facilitate the care of bedridden patients, without creating inconvenience for the patient, which is typical for models already existing on the market. The work is carried out within the framework of the Priority 2030 strategic academic leadership program.
Bedridden patients often suffer from bedsores - local tissue necrosis caused by prolonged compression. To avoid bedsores, the patient must be turned over once every two hours or use special anti-bedsore mattresses: they allow one way or another to redistribute the pressure of the patient’s body on the surface of the bed. The most common mattresses have air chambers, the pressure inside of which is regulated using a compressor. However, the constant noise of the compressor causes inconvenience to the patient and interferes with sleep and rest.
The prototype of the anti-decubitus mattress is made using ring actuators that are capable of creating controlled, point pressure on the patient’s body. The flexible ring actuator is a mineral oil-filled cell with two electrodes. Under the influence of electric current, the electrodes are attracted to each other, displacing the oil to the edges of the cell. Thus, the actuator thickens at the edges in the same way as the cells of an anti-decubitus mattress, powered by a compressor, expand.
Apple patents sensors for detecting heart pathologies for AirPods Max
The possible presence of heart pathologies will be detected using two microphones (one in each earphone), a special processor and a neural network. Microphones will send a special signal into the ear to detect heart activity. The individual's performance will then be compared to monitoring benchmarks. The result will make it clear about possible heart problems (bradycardia, tachycardia and other disorders).
Source: https://the-geek.ru/news/apple-zapatentovala-datchik-obnaruzhenija-patologij-serdca-dlja-airpods-max
News
